Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder

INTRODUCTION: Current WHO guidelines recommend using methadone or buprenorphine as maintenance treatments for maternal opioid use disorder. However, buprenorphine‐naloxone, with a lower abuse risk than buprenorphine monotherapy or methadone, offers a potentially beneficial alternative, but scientifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanervo, Minna M., Tupola, Sarimari J., Nikkola, Eeva M., Rantakari, Krista M., Kahila, Hanna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Pregnancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951318/
https://www.ncbi.nlm.nih.gov/pubmed/36562462
http://dx.doi.org/10.1111/aogs.14497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951318/
https://www.ncbi.nlm.nih.gov/pubmed/36562462
http://dx.doi.org/10.1111/aogs.14497

Ejemplares similares